Meningitis and spinal abscess Report on continuing nursing education (CNE) program Dual lipid-lowering therapy: Maximizing IDL-C reduction through complementary mechanisms Calvarial Osteomyelitis & CSF Leak Management Post Pituitary Surgery Journal Scan Editorial Diffuse axonal injury grade III Cerebral venous thrombosis Arrhythmogenic right ventricular cardiomyopathy presenting with sustained ventricular tachycardia in an adolescent male: A case report Imaging the Invisible: Paediatric Venous Malformation of the Ankle with DSA Confirmation Clinical pharmacy perspective: Can antiplatelet therapy be used for preventing thrombus formation in the left atrium and apical clot
10.1038/nrc2399 12 BushwellerJ
Sen, S., Kawahara, B., Gupta, D., Tsai, R., Khachatryan, M., Roy-Chowdhuri, S
The primary drawbacks of pharmacological glucagon therapy for metabolic syndrome, aside from hyperglycemia, are hemodynamic properties that include effects of increased heart rate and cardiac contractility [138]